Elanco’s pending acquisition of Bayer Animal Health
ELANCO Animal Health Incorporated recently announced that the European Commission has granted approval of Elanco’s pending acquisition of Bayer AG’s animal health business. The company continues to progress toward a mid-year closing, anticipated August 3, 2020. Elanco president and CEO Jeff Simmons said, “Approval from the European Commission is an important milestone towards the completion…
Details